Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 464

1.

Prevalence and Characteristics of Pediatric Healthcare Workers without Immunity to Varicella zoster Virus.

Anugulruengkitt S, Puthanakit T, Siengboon S, Paitoonpong L, Kowitdamrong E, Pancharoen C, Pichitchok Y.

Jpn J Infect Dis. 2017 Mar 24;70(2):216-218. doi: 10.7883/yoken.JJID.2016.227. Epub 2016 Aug 31.

2.

Digital epidemiology reveals global childhood disease seasonality and the effects of immunization.

Bakker KM, Martinez-Bakker ME, Helm B, Stevenson TJ.

Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):6689-94. doi: 10.1073/pnas.1523941113. Epub 2016 May 31.

3.

Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination.

Qi Q, Cavanagh MM, Le Saux S, NamKoong H, Kim C, Turgano E, Liu Y, Wang C, Mackey S, Swan GE, Dekker CL, Olshen RA, Boyd SD, Weyand CM, Tian L, Goronzy JJ.

Sci Transl Med. 2016 Mar 30;8(332):332ra46. doi: 10.1126/scitranslmed.aaf1725.

4.

Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination.

Betta M, Laurino M, Pugliese A, Guzzetta G, Landi A, Manfredi P.

Proc Biol Sci. 2016 Mar 16;283(1826):20160054. doi: 10.1098/rspb.2016.0054.

5.

Varicella zoster virus related deaths and hospitalizations before the introduction of universal vaccination with the tetraviral vaccine.

de Martino Mota A, Carvalho-Costa FA.

J Pediatr (Rio J). 2016 Jul-Aug;92(4):361-6. doi: 10.1016/j.jped.2015.10.003. Epub 2016 Mar 8.

6.

Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections.

Sauerbrei A.

Eur J Clin Microbiol Infect Dis. 2016 May;35(5):723-34. doi: 10.1007/s10096-016-2605-0. Epub 2016 Feb 12. Review.

PMID:
26873382
7.

A highly conserved epitope-vaccine candidate against varicella-zoster virus induces neutralizing antibodies in mice.

Zhu R, Liu J, Chen C, Ye X, Xu L, Wang W, Zhao Q, Zhu H, Cheng T, Xia N.

Vaccine. 2016 Mar 18;34(13):1589-96. doi: 10.1016/j.vaccine.2016.02.007. Epub 2016 Feb 9.

PMID:
26873057
8.

Varicella vaccination in pediatric oncology patients without interruption of chemotherapy.

van de Wetering MD, Vossen MT, Jansen MH, Caron HN, Kuijpers TW.

J Clin Virol. 2016 Feb;75:47-52. doi: 10.1016/j.jcv.2016.01.004. Epub 2016 Jan 7.

9.
10.

Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

Aoki T, Koh K, Kawano Y, Mori M, Arakawa Y, Kato M, Hanada R.

Biol Blood Marrow Transplant. 2016 Apr;22(4):771-5. doi: 10.1016/j.bbmt.2015.12.025. Epub 2015 Dec 31.

11.

Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.

van Lier A, Lugnér A, Opstelten W, Jochemsen P, Wallinga J, Schellevis F, Sanders E, de Melker H, van Boven M.

EBioMedicine. 2015 Aug 8;2(10):1494-9. doi: 10.1016/j.ebiom.2015.08.017. eCollection 2015 Oct.

12.

Incidence and case-fatality of varicella-zoster virus infection among pediatric cancer patients in developing countries.

Ojha RP, Stallings-Smith S, Aviles-Robles MJ, Gomez S, Somarriba MM, Caniza MA.

Eur J Pediatr. 2016 Apr;175(4):581-5. doi: 10.1007/s00431-015-2672-8. Epub 2015 Nov 26.

PMID:
26608932
13.

Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.

Hayashida K, Ozaki T, Nishimura N, Gotoh K, Funahashi K, Nakane K, Gomi Y, Manabe S, Ishikawa T, Yamanishi K.

J Immunol Methods. 2015 Nov;426:50-5. doi: 10.1016/j.jim.2015.07.011. Epub 2015 Jul 29.

PMID:
26232696
14.

[Vaccines against varicella-zoster virus (VZV)].

Salleras L, Salleras M, Soldevila N, Prat A, Garrido P, Domínguez Á.

Enferm Infecc Microbiol Clin. 2015 Jun-Jul;33(6):411-23. doi: 10.1016/j.eimc.2015.05.005. Epub 2015 Jun 19. Spanish.

PMID:
26096575
15.

Outbreak of varicella in a highly vaccinated preschool population.

Fu J, Wang J, Jiang C, Shi R, Ma T.

Int J Infect Dis. 2015 Aug;37:14-8. doi: 10.1016/j.ijid.2015.06.003. Epub 2015 Jun 10.

16.

[Embryonal varicella. To the Editors].

Endre C.

Orv Hetil. 2015 May 31;156(22):903-4. doi: 10.1556/650.2015.22M. Hungarian. No abstract available.

PMID:
26004551
17.

The social contact hypothesis under the assumption of endemic equilibrium: Elucidating the transmission potential of VZV in Europe.

Santermans E, Goeyvaerts N, Melegaro A, Edmunds WJ, Faes C, Aerts M, Beutels P, Hens N.

Epidemics. 2015 Jun;11:14-23. doi: 10.1016/j.epidem.2014.12.005. Epub 2015 Jan 10.

18.

[Sero-epidemiology of VZV infection in Italy: impact evaluation of extensive vaccination].

Gabutti G, Rota MC, De Donno A, Guido M, Bella A, Idolo A, Lupi S, Brignole G; Gruppo di studio sulla sieroepidemiologia..

Epidemiol Prev. 2014 Nov-Dec;38(6 Suppl 2):57-61. Italian.

19.

Laboratory investigations of vaccinated patients with varicella.

Siedler A, Dettmann M, Tolksdorf K, Polte C, Walter C, Ehlers B.

Vaccine. 2015 Apr 15;33(16):1968-73. doi: 10.1016/j.vaccine.2015.02.057. Epub 2015 Mar 1.

PMID:
25738815
20.

The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.

Ouwens MJ, Littlewood KJ, Sauboin C, Téhard B, Denis F, Boëlle PY, Alain S.

Clin Ther. 2015 Apr 1;37(4):816-829.e10. doi: 10.1016/j.clinthera.2014.12.017. Epub 2015 Feb 26.

Supplemental Content

Loading ...
Support Center